We’ve sliced and diced our portfolio into distinct “trends” that define our edge.
We are pleased to report that as of April 2021 the SOSV Climate Tech 100 have raised $1.85 billion from investors and have a market cap of $5.65 billion. The average company is four years old. SOSV (our parent fund) has invested $89 million in these companies and was in most cases the first investor, though we continued investing through early rounds.
IndieBio has never been one to shy away from the riskiest and most impactful investments for our planet. In fact, we embrace them.
Boosting female representation in the startup world is an ongoing challenge, but we’re dedicated to gender balance, not only because it’s the right thing to do, but because we would be dismissing impressive companies otherwise. We’ve found that more gender balance leads to better workplace culture and better ideas being exchanged.
Future of Food
It’s not just that we can make meat and fish in the lab, or with mushrooms and chickpeas. It’s not just that AI can predict the best plant ingredients to make the best tasting milk and yogurt. And it’s not just that yeast can be fermented to produce the healthier and better food preservatives. We’re diving deep every day into the foods that will satisfy novelty-seekers and conventionalists alike.
We’re putting big bets on the newest technologies and trends we think are ahead of the curve.
Future of Medicine
Medicine ain’t what it used to be. Today, bloodletting, skull-drilling and giving children cocaine for toothaches are relics of the past. Tomorrow, so too will addictive opioids, chemotherapy, and psychiatric drugs that are non-selectively bathing our bodies in chemicals.
The future of medicine is an exciting one, and we’re excited to share the most exciting technologies that enable the next wave of medicine and healthcare.
Our mission has always been Human and Planetary Health from the beginning, so it’s hard to say which of our companies are “impact” companies (in some ways, they all are).
Here, we narrowed down the startups that are directly addressing sustainability issues, improving public health, mitigating inequality, and democratizing access to infrastructure and technologies.
Every season of the year, a new batch and about one-sixth of our alumni are in raise mode. These companies are currently raising and would love to talk to interested investors. We can set up those meetings or you can contact the companies directly.
In America alone, an estimated 12 million tons of textile waste – equivalent to 85% of all textiles – end up in landfills on a yearly basis, because recycling is not trivial. There are almost two dozen methods to recycle specific fiber types, ONLY if the garment waste happens to be 100% of a single […]
For billions of people, cell and gene therapies offer the possibility of curing incurable diseases, but access to these life saving treatments feels out of reach as large scale manufacturing remains one of the biggest bottlenecks in producing these game changing solutions. These therapies can cost as much as $3.5M per patient and 30% of clinical trials […]
For centuries, chocolate has been a staple ingredient and sweet treat in diets all over the world, but its future is in trouble. Chocolate production has long been associated with significant carbon emissions and deforestation, with a looming supply deficit predicted by 2030. To save chocolate, Nukoko is transforming the industry with its sustainable and […]
In discussions surrounding climate change, there is often a focus on the negative impacts of high carbon levels in the atmosphere. However, it’s important to recognize that carbon itself is not our adversary. Instead, CroBio is leading the charge against years of unsustainable practices by restoring the balance of carbon between the soil and the […]
Drug development costs over $2 billion per drug with a failure rate of 90% because in vitro methods do not mimic the systemic organization of the human body and animal models are too different from Humans. As a result, the limitations of in vitro testing reduce the probability to develop safe and efficient drugs for patients needing them and […]
Pneuma is developing the next generation of sustainable materials – implementing the process of photosynthesis as a product feature. OXYA, their living and breathing textile, is seeded with microalgae that consume carbon dioxide and produce oxygen. Pneuma’s vision is to help nature in the production of oxygen by transforming human-made materials – aiming for technology […]
Biomage’s Cellscope technology provides world-class quality analytical insight: simple data upload, data integration for batch effect correction, beautiful publication-quality figures, and much more.